Curriculum Vitae. Acibadem Maslak Hospital Department of Medical Oncology Büyükdere Cad No:40 Maslak Istanbul TURKEY Tel: - PDF

Description
Curriculum Vitae Full Name: Ozlem ER Date&Place of Birth: 1970, Izmir, TURKEY Office Contact: Academic Title&Department: Academic Qualifications: Acibadem Maslak Hospital Department of Medical Oncology

Please download to get full document.

View again

of 9
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Information
Category:

Documents

Publish on:

Views: 81 | Pages: 9

Extension: PDF | Download: 0

Share
Transcript
Curriculum Vitae Full Name: Ozlem ER Date&Place of Birth: 1970, Izmir, TURKEY Office Contact: Academic Title&Department: Academic Qualifications: Acibadem Maslak Hospital Department of Medical Oncology Büyükdere Cad No:40 Maslak Istanbul TURKEY Tel: Associate Professor of Internal Medicine and Medical Oncology, Acibadem Maslak Hospital, Istanbul, Turkey MD, Hacettepe University Medical Faculty, Ankara, TR 1999 INTERNAL MEDICINE SPECIALIST, Ankara Numune Hospital, TR 2002 MEDICAL ONCOLOGY SPECIALIST, Erciyes University, TR MD Anderson Cancer Center, Breast Medical Oncology, USA AVON-AACR Cancer Biology Fellow, TJU, USA Academic Interests: Solid tumors- breast cancer, colorectal cancer, lung cancer-, targeted therapy, thrombosis in cancer patients Researchs/Projects: I have participated in several national and international multicenter clinical studies. Experience Abroad: MD Anderson Cancer Center, Medical Oncology Department October March 2004 (Clinical observer under supervision of Prof Gabriel N. Hortobagyi) Thomas Jefferson University, Philadelphia, PA AVON-AACR Cancer Biology Fellow Memberships: ASCO Associate Member ESMO Full Member (CERTIFICATED) Awards: AACR Member Turkish Oncology Group Member 29 th ESMO Travel Award (Vienna, 2004) Clinical Course Of Breast Cancer Patients With Liver Metastases Only Treated With Chemotherapy. Ozlem Er, Debbie Frye, Kristine Broglio, Vicente Valero, Gabriel N. Hortobagyi, Banu Arun. Journal of Thrombosis and Haemostasis 2004 Young Investigator Prize A Randomized Clinical Trial Of Combination Chemotherapy With And Without Low Molecular Weight Heparin In Small Cell Lung Cancer. Mustafa Altinbas, Hasan Senol Coskun, Ozlem Er, Metin Ozkan, Bulent Eser, Ali Unal, Mustafa Cetin, Serdar Soyuer. Avon Foundation-American Association for Cancer Research International Scholars Award in Breast Cancer Research (2006) Role of Caveolin in breast cancer pathogenesis Publications A. Papers Published in Peer-Reviewed Journals : A1. Mustafa Cetin, Yusuf Ozkul, Ali Unal, Bulent Eser, Omer Ozturk, Recep Kutlubay, Ozlem Er, Hatice Burakgazi. The effect of medroxyprogesterone acetate on bone marrow and testis during cytotoxic chemotherapy. Cell Biology and Toxicology, 16, (2000) A2. Mustafa Cetin, Bulent Eser, Ozlem Er, Ali Unal, Mehmet Bilgin. Extreme thrombocytosis after penetrating femoral venous injury. Hematology, 6, (2001) A3. Bulent Eser, Mustafa Cetin, Olgun Kontas, Ali Unal, Ozlem Er, Hasan S Coskun, Mustafa Altınbas. Facial nerve paralysis and paraplagia as presenting symptoms of acute leukemia. Japan J Clin Oncol 31(2), (2001) A4. Ozlem Er, H.Senol Coskun, Mustafa Altınbas, Hulya Akgun, Mustafa Cetin, Bulent Eser, Ali Unal. Rapidly relapsing squamous cell carcinoma of renal pelvis associated with paraneoplastic syndromes of leukocytosis, thrombocytosis and hypercalcemia. Urologia Internationalis 67, (2001) A5. Mustafa Cetin, Bulent Eser, Ozlem Er, Ali Unal, Eser Kılıc, Tahir Patıroğlu, Hasan S Coskun, Mustafa Altınbas, Onder Arslan, Osman İlhan. Effects of DMSO on platelet functions and P-Selectin expression during storage. Transfusion and Apheresis Science 24, (2001) A6. Isın Soyuer, Serdar Soyuer, Ozlem Canoz, Ozlem Er, Yucel Arıtas. Correspondence. Cytopathology 13 (3), 177 (2002) A7. Berna Oksuzoğlu, Ozlem Er, Mehmet Guler,Mutlu Doğanay, Mustafa Esen, Nuri Aydın Kama. Disseminated high grade malignant lymphoma involving both of the breasts. The Breast 11: (2002) A8. Mustafa Altınbas, Ozlem Er, Metin Ozkan,Hasan S Coskun, İnci Gulmez, Eyup Ekici, Bunyamin Kaplan, Bulent Eser, Mustafa Ozesmi. Ifosfamide, mesna and interferon alfa combination chemoimmunotherapy in malignant mesothelioma:results of a single center in Central Anatolia. Medical Oncology 21(4): (2004) A9. Bunyamin Kaplan, Mustafa Altınbas, Celalettin Eroğlu, Eray Karahacıoğlu, Ozlem Er, Metin Ozkan, Mehmet Bilgin, Ozlem Canoz, İnci Gulmez, Mustafa Gulec. Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small cell lung cancer (NSCLC). American Journal of Clinical Oncology 27 (6): (2004) A10. Metin Ozkan, Mustafa Altinbas, Ozlem Er, Bunyamin Kaplan, Hasan Senol Coskun, Eray Karahacioğlu, Ahmet Menku, Yasemin Cihan, Olgun Kontas, Hidayet Akdemir. Post-operative sequential chemoradiotherapy in high-grade cerebral gliomas with fotemustine. Journal of Chemotherapy 16 (3): (2004) A11. Metin Ozkan, Ozlem Er, Bunyamin Kaplan, Mustafa Altinbas, Bulent Ozcelik, Fatma Tokat, Edip Torun, Okkes Ibrahim Karahan. 2 Presentation with superior vena cava syndrome secondary to solitary lung metastasis mimicking primary lung cancer following resection of a uterine malignant mixed mullerian tumor. Eur J Obs Gyn & Rep Biol 118 (2): (2005). A12. M Ozkan, B Eser, Ozlem Er, F Altuntas, R Coskun, R Topsakal, E Mavili, M Kala, M Altinbas. Antiphospholipid syndrome associated with malignant mesothelioma presenting with superior vena cava thrombosis: A case report. Clin Appl Throm Hemos 10 (4): (2004) A13. Mustafa Altinbas, Hasan S. Coskun, Ozlem Er, Metin Ozkan, Bulent Eser, Ali Unal, Mustafa Cetin, Serdar Soyuer. A randomized clinical trial of combination chemotherapy with and without low molecular weight heparin in small cell lung cancer. J Throm Hemostasis 2 (8): (2004) A14. Ozlem Er, Hasan S. Coskun, Mustafa Altinbas, Metin Ozkan, Bulent Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Meropenem +/- granulocyte colony stimulating factor in the treatment of febrile neutropenic patients with cancer: Prospective randomized study. Journal of Chemotherapy 16 (3): (2004) A15. Bulent Eser, Fevzi Altuntas, Ozlem Er, Olgun Kontas, Ayten Ferahbas, Mustafa Cetin, Ali Unal. A case of subcutaneous panniculitis like T-cell lymphoma with hemophagocytosis secondary to chemotherapy. JEADV 18 (6): (2004) A16. Gulmez I, Kart L, Buyukoglan H, Er O, Balkanli S, Ozesmi M. Evaluation of malignant mesothelioma in central Anatolia: a study of 67 cases. Can Respir J 11(4): (2004). A17. Mustafa Altinbas, Ozlem Er, Metin Ozkan, Yusuf Solak, H. Senol Coskun, Can Kucuk, Sebnem Gursoy. Irinotecan Plus Cisplatin Combination Against Metastatic Gastric Cancer: Phase II Study. Medical Oncology 2005; 22(2): A18. Hasan Senol Coskun, Ozlem Er, Serdar Soyuer, Mustafa Altınbas, Bulent Eser,Eray Karahacioglu, Fevzi Altuntas. Solitary Plasmacytoma: Experiences From Central Anatolia. Irish J Med Sci 2005 Jan- Mar;174(1):33-6. A19. O. Er, M. Ozkan, M. Altinbas, H.S. Coskun, B. Eser, F. Altuntas, M. Cetin, A. Unal. Outpatient 5-fluorouracil+α-interferon+interleukin-2 chemoimmunotherapy in metastatic renal cell cancer patients Asia- Pacific J Clin Oncol, 1, (2005) A20. Dogu GG, Ozkan M, Er O, Eser B, Altinbas M. Squamous cell carcinoma of colorectal cancer: adjuvant radiotherapy is necessary? Eur J Cancer Care (Engl) Dec;14(5):465. A21. M. Ozkan, B. Eser, O. Er, H. S. Coskun, A. Ozturk, I. Sari, O. Canoz, M. Altinbas. Bone marrow involvement in small cell lung cancer: Prognostıc significance and correlation with hematological and biochemical parameters Asia Pacific J Clin Oncol, 2, (2006). A22. B Eser, B Kaplan, A Unal, O Canoz, F Altuntas, HI Sari, Ozlem Er, Metin Ozkan, Can Kucuk, Makbule Arar, Sebnem Gursoy, and Mustafa Cetin. Clinicopathologic Characteristics and Therapeutic Outcomes Of Primary Gastrointestinal Non-Hodgkin s Lymphomas in Central Anatolia, 3 in Turkey. Yonsei Medical Journal 2006 Feb 28;47 (1): A23. Eser B, Sari I, Canoz O, Altuntas F, Cakmak E, Ozturk A, Ozkan M, Er O, Cetin M, Unal A. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. Am J Hematol May;81(5): A24. Bulent Eser, Fevzi Altuntas, Işın Soyuer, Ozlem Er, Ozlem Canoz, Hasan S Coskun, Mustafa Cetin, Ali Unal. Acute Lymphoblastic Leukemia Associated with Brucellosis in Two Patients with Fever and Pancytopenia. Yonsei Medical Journal 2006; 47(5): A25. Nihat Kalay, Emrullah Basar, Ibrahim Ozdogru, Ozlem Er, Yakup Cetinkaya, Ali Dogan, Tugrul Inanc, Abdurrahman Oguzhan, Namik Kemal Eryol, Ramazan Topsakal, Ali Ergin. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol Dec 5;48(11): A26. Ozlem Canoz, Metın Ozkan, Vedat Arsav, Ozlem Er, HS Coskun, S Soyuer, M Altinbas. The role of c-erbb-2 expression on the survival of patients with small-cell lung cancer. Lung 2006; 184(5): A27. Ozlem Er, Leo R Zacharski. Management of cancer-associated thrombosis. Vascular Health and Risk Management 2006; 2(4): A28. M Sofikerim, I Gulmez, F Tokat, Ozlem Er, I Gulmez. Epidermoid carcinoma of the lung with isolated penile metastasis. Can J Urol Aug;14(4): A29. Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M, Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer. Med Oncol. 2007;24(4): A30 Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun U,Camci C, Buyukberber S. Gemcitabine plus Capecitabine Combination in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines and Taxanes. Oncology. 2007;72(5-6): A31 O Er, DK Frye, SC Kau, K Broglio, V Valero, GN Hortobagyi, B Arun. Clinical Course of Breast Cancer Patients with Metastases Limited to the Liver Treated with Chemotherapy. Cancer J 2008; 14(1): A32. Coskun U, Buyukberber S, Yaman E, Uner A, Er O, Ozkan M, Dikilitas M, Oguz M, Yildiz R, B DY, Kaya AO, Benekli M. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. Neoplasma 2008;55(1): A33. O Er, S Mistik, M Ozkan, A Ozturk, M Altinbas. Factors related to complementary/alternative medicine use among cancer patients in Central Anatolia. Tumori 2008; 94: A34. Dogu GG, Ozkan M, Ozturk F, Dikilitas M, Er O, Ozturk A. Triplenegative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin. Med Oncol Jan 21. 4 A35. Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, Milliman JN, Knudsen ES, Zhou J, Wang C, Pestell RG, Lisanti MP. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. Am J Pathol Feb;174(2): A36. Karaoglu A, Arslan UY, Ozkan M, Kalender ME, Alici S, Coskun U, Gumus M, Celenkoglu G, Er O, Sevinc A, Buyukberber S, Alkis N, Benekli M. Efficacy and toxicity of gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer. Asian Pac J Cancer Prev 2009 Jan-Mar; 10 (1): A37. Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R, Benekli M; Anatolian Society of Medical Oncology. Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer. J Natl Med Assoc Aug;101(8): A38. Er O. Cancer stem cells in solid tumors. Onkologie Oct;32(10): A39. Karaca H, Lale A, Dikilitas M, Ozkan M, Er O. Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature. Med Oncol Oct 15. A40. Hasan Senol COSKUN, Mustafa ALTINBAS, Ozlem ER, Figen OZTURK, Hatice KARAMAN, Serdar SOYUER, Metin OZKAN, Isin SOYUER. Human epidermal growth factor receptor 2 oncoprotein expression in breast cancer patients from central Anatolia, Turkey. Asia Pacific Journal of Clinical Oncology 2009;5: B. Oral and Poster Presentations at International Meetings : B1. H. S. Coskun, B. Eser, M. Cetin, A.Unal, M. Altınbas, O. Er, E. Karahacıoğlu, B. Kaplan. Hodgkin Disease: results of single center in Central Anatolia of Turkey. American Society of Clinical Oncology. Thirtysixth Annual Meeting May 20-23, 2000-New Orleans, LA, USA B2. Ozlem Er, H.Senol Coskun, Mustafa Altınbas, Bulent Eser, Muzaffer Keklik, Mustafa Cetin, Eray Karahacıoğlu, Ali Unal. Efficacy of vinorelbine and doxorubicine combination chemotherapy in metastatic breast cancer. European School of Oncology 2 nd Milan Breast Cancer Congress June 14-16, 2000,Milan, Italy. B3. A Unal, M Cetin, B Eser, S Gucer, M Tayyar, O Er, HS Coskun. Activated protein C resistance in Turkish women with pre-eclampsia. 5 th Annual Meeting of the European Haematology Association, p:500, June 2000, Birmingham, UK. B4. H. Senol Coskun, Ozlem Er, Mustafa Altınbas, Fatih Tanrıverdi, Bulent Eser, Ali Unal, Mustafa Cetin. Adjuvant treatment of locally advanced gastric cancer. A retrospective analysis. 25th European Society for Medical Oncology Congress, October 2000, Hamburg, Germany. Annals of Oncology 2000, 11(Suppl 4): p117. B5. Ali Unal, Bulent Eser, Mustafa Cetin, Mustafa Altınbas, Eray 5 Karahacıoğlu, Olgun Kontas, Bunyamin Kaplan, Ozlem Er, Senol Coskun. Clinico-pathologic characteristics of non-hodgkins lymphoma patients at single center in Central Anatolia. 25th European Society for Medical Oncology Congress, October 2000, Hamburg Germany. Annals of Oncology 2000, 11(Suppl 4): 102. B6. M Altınbas, HS Coskun, O. Er, M Ozkan, B Eser, A Unal, M Cetin. Prospective randomized study of epirubicine cyclophosphamide and vincristine combination chemotherapy (CEV) + low molecular weight heparin (LMWH) in small cell lung cancer. Proceedings of ASCO VOL ; 321a. B7. Ozlem Er, HS Coskun, M.Altınbas, B.Eser, M.Cetin, A.Unal. Epidemiological characteristics and results of adjuvant treatment of colorectal cancer patients from Erciyes University Oncology Hospital in Turkey. Proceedings of ASCO vol ;114b B8. Ozlem Er, HS Coskun, M.Altınbas, İ.Gulmez, B.Eser, M.Cetin, A.Unal. Cisplatin and etoposide versus cisplatin and vinorelbine:a retrospective comparison in patients with advanced nonsmall cell lung cancer. International Symposium Lung Cancer and Bronchoscopy 29 Aug-1Sep B9. M.Altınbas, O. Er, HS Coskun, S.Soyuer, A.Unal, E,Karahacıoğlu. Palliative chemotherapy in inoperable or metastatic pancreatic carcinoma. 4th International Conference on Biology, Prevention and Treatment of Gastrointestinal Malignancies Sep 6-8,2001; 84. B10. M.Altınbas, O. Er, HS Coskun, E.Ekici, İ.Gulmez, M.Ozesmi. Ifosfamide, mesna and interferon alfa combination therapy in malignant mesothelioma:results of a single center in central anatolia, Turkey. European J Cancer 2001: vol 37 sup 6; B11. HS Coskun, O. Er, M.Altınbas, B.Eser, A.Unal, M.Cetin. Efficacy of cisplatin etoposide combination in anthracycline refractory metastatic breast cancer. The Breast Journal 2001;7(5): 43. B12. HS Coskun, O. Er, M.Altınbas, O. Coban, M.Cetin, B.Eser. Docetaxel and doxorubicin combination in salvage therapy of metastatic breast cancer. The Breast Journal 2001;7(5): B13. Ozlem Er, HS Coskun, M.Altınbas, B.Eser, A.Unal, M.Cetin. Paclitaxel and epirubicin combination therapy in metastatic breast cancer patients. The Breast Journal 2001;7(5): 69. B14. Ozlem Er, HS Coskun, I. Soyuer, M.Altınbas. Late onset of local recurrence and distant metastases from breast cancer. The Breast Journal 2001;7(5): 71. B15. Ali Unal, Mustafa Cetin, Bulent Eser, Turkan Patıroğlu, Senol Coskun, Ozlem Er, Bunyamin Kaplan, Mustafa Altınbas. Autologous Peripheral Blood Stem Cell Transplantation In Patients with Resistant and/or Relapsing Lymphoma: Single center experience. Blood 2001; 98(11): 400b. B16. M. Altınbas, F.N. Aykan, M. Erkisi, E. Buyukunal, İ. Yucel, N. Gunel, O. Er, N, Uskent, H. Akbulut, R. Disci, H. Camlıca, D. Fırat. Alternating combination of irinotecan with 5-fluorpuracil and folinic acid in first line chemotherapy of metastatic colorectal cancer (a Turkish Oncology Group 6 study). American Society of Clinical Oncology. Thirty-Eighth Annual Meeting May 18-21, 2002 Orlonda FL, USA Prog Proceedings of ASCO Vol: 21, 2002 Abstract: B17. Ozlem Er, Senol Coskun, Yusuf Solak, Mustafa Altınbas. Irinotecan Plus Cisplatin Combination Against Metastatic Gastric Adenocarcinoma: Preliminary Results of Phase II Study. American Society of Clinical Oncology. Thirty-Eighth Annual Meeting May 18-21, 2002 Orlando FL, USA Prog Proceedings of ASCO Vol: 21, 2002 Abstract: B18. B.Eser, A.Unal, M. Baskol, M. Cetin, E. Cakmak, H.S. Coskun, O. Er. Elevated transaminase levels in patients with vitamin B12 Deficiency. 7 th Meeting of the European Hematology 6-9 June 2002, Italy. The Hematology Journal 2002; 3(Supply 1): 384. B19. A.Unal, B.Eser, O. Canoz, B. Kaplan, H.İ. Sarı, H.S. Coskun, O. Er, M. Altınbas, M. Cetin. Clinicopathologic characteristics and prognostics factors of primary gastrointestinal non-hodgkin s lymphoma. 7 th Meeting of the European Hematology 6-9 June 2002, Italy. The Hematology Journal 2002; 3(Supply 1): B20. Ozlem Er, Hasan Senol Coskun, M.Altınbas, Metin Ozkan, Bulent Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Meropenem +/- granulocyte colony stimulating factor in treatment of febrile neutropenic patients in cancer: Prospective randomized study. 27 th ESMO Congress, October, 2002: Nice, France, 5 (supp 717p):194. B21. M.Altınbas, Ozlem Er, Hasan Senol Coskun, Metin Ozkan, Bulent Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Gemcitabin and cisplatin in the treatment of advanced or metastatic pancreatic cancer. 27 th ESMO Congress, October, 2002: Nice, France, 5 (supp 717p):194. B22. H.Senol Coskun, Mustafa Altınbas, Ozlem ER, Figen Ozturk, Hatice Karaman, Serdar Soyuer, Metin Ozkan, Isın Soyuer. HER2 expression in Turkish breast cancer patients from a single center. 27 th ESMO Congress, October, 2002: Nice, France, 5 (supp 41p):194. B23. Ozlem Er, Yusuf Ozkul, Mustafa Altinbas, Sebnem Gursoy, H.Senol Coskun, Metin Ozkan, Serpil Tekin, Hilal Akalin. K-ras codon 12 mutations in colorectal cancer patients. American Society of Clinical Oncology Annual Meeting May 31-June 3, 2003 Chicago Illinois, USA Prog Proceedings of ASCO 2003 Vol 22 p308, no:1238 B24. Mustafa Altinbas, Metin Ozkan, Ozlem Er, Hatice Everest, H.Senol Coskun, Ahmet Menku, Yasemin Cihan, Bunyamin Kaplan. Adjuvant radiotherapy and fotemustine in treatment of anaplastic astrocytoma and glioblastoma multiforme patients. ASCO Annual Meeting May 31- June 3, 2003 Chicago Illinois, USA Prog Proceding of ASCO 2003 Vol 22, p:115, no:459 B25. Bunyamin Kaplan, Mustafa Altınbas, Celalettin Eroğlu, Eray Karahacıoğlu, Ozlem Er, Metin Ozkan, Mehmet Bilgin, Ozlem Canoz, İnci Gulmez, Mustafa Gulec. A phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) with concurrent thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small cell lung cancer (NSCLC). ASCO Annual Meeting May 31-June 3, 2003 Chicago Illinois, USA Prog Proceedings of ASCO 2003 Vol 22, p:704, no:2832. B26. B Eser, F Altuntas, B Kaplan, O Canoz, M Ozkan, O Er, HS Coskun, 7 K Gundogan, M Cetin, A Unal. Results of first line treatment in Hodgkin s disease: Single center experience. 8 th Annual Congress of the European Haematology Association, June 2003, Lyon, France, no:0355 B27. F Altuntas, B Eser, O Canoz, O Er, M Ozkan, B Kaplan, A Sahin, M Cetin, A Unal. Fludarabine and fludarabine based combination chemotherapy in chronic lymphocytic leukemia/lymphoma. 8 th Annual Congress of the European Haematology Association, June 2003, Lyon, France, no:0623, p:190. B28. Ozlem Er, Metin Ozkan, Mustafa Altinbas, H. Senol Coskun, Bulent Eser, Fevzi Altuntas, Mustafa Cetin, Ali Unal. 5-fluorouracil+interferon alfa+ interleukin-2 chemoimmunotherapy in metastatic renal cell cancer patients. ASCO 40 th Annual Meeting 2004 New Orleans, USA Prog Proceedings of ASCO Vol 23, B29. H.S. Coskun, O. Er, M. Ozkan, B. Eser, M. Altinbas. Adjuvant sequential docetaxel and cyclophosphamide-doxorubicin combination
Related Search
Similar documents
View more...
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks